Related Experiment Video
Updated: Jun 29, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
A successful desensitization in an adult patient with ARA-C infusion reaction
Yasemin Akgul Balaban1, Mustafa Ilker Inan1, Ali Selcuk1
1Division of Immunology and Allergic Diseases, Gulhane Training and Research Hospital, Ankara, Turkiye.
Introduction:
Cytarabine (ARA-C) is an antimetabolite agent used especially in the treatment of hematologic malignancies. Infusion reactions have an important place among the side effects that may occur due to treatment. Clinical findings of infusion reactions resemble allergic reactions.
Case Report:
47-year-old male patient with a diagnosis of B-cell Acute Lymphoblastic Leukaemia developed infusion reaction during ARA-C treatment.
Management & Outcome:
There was no alternative treatment option for his existing malignant disease, we decided ARA-C desensitization.
Discussion:
We would like to describe a successful desensitization protocol in an adult patient who experienced a reaction during ARA-C infusion.
Related Concept Videos
Desensitization and Tachyphylaxis
Allergic Reactions
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

